IDEAYA Biosciences Inc (IDYA)
29.97
+0.72
(+2.46%)
USD |
NASDAQ |
Oct 04, 16:00
29.97
0.00 (0.00%)
After-Hours: 20:00
IDEAYA Biosciences Shareholders Equity (Annual): 621.09M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 621.09M |
| December 31, 2022 | 349.46M |
| December 31, 2021 | 301.51M |
| December 31, 2020 | 198.27M |
| Date | Value |
|---|---|
| December 31, 2019 | 100.40M |
| December 31, 2018 | -48.95M |
| December 31, 2017 | -15.74M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
100.40M
Minimum
2019
621.09M
Maximum
2023
314.15M
Average
301.51M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Amgen Inc | 6.232B |
| Gilead Sciences Inc | 22.83B |
| Eli Lilly and Co | 10.77B |
| Black Diamond Therapeutics Inc | 116.74M |
| Tango Therapeutics Inc | 253.11M |